Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 994 JPY 0.54% Market Closed
Market Cap: 445.6B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Gross Margin
Kobayashi Pharmaceutical Co Ltd

53.9%
Current
56%
Average
31.7%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.9%
=
Gross Profit
91B
/
Revenue
168.8B

Gross Margin Across Competitors

Country JP
Market Cap 445.6B JPY
Gross Margin
54%
Country JP
Market Cap 121T JPY
Gross Margin
67%
Country FR
Market Cap 181.1B EUR
Gross Margin
74%
Country UK
Market Cap 113.9B GBP
Gross Margin
0%
Country IN
Market Cap 5.5T INR
Gross Margin
52%
Country UK
Market Cap 34.7B GBP
Gross Margin
62%
Country DE
Market Cap 27.8B EUR
Gross Margin
58%
Country US
Market Cap 26.8B USD
Gross Margin
72%
Country JP
Market Cap 3T JPY
Gross Margin
38%
Country IN
Market Cap 1.1T INR
Gross Margin
56%
Country IN
Market Cap 902.9B INR
Gross Margin
49%
No Stocks Found

Kobayashi Pharmaceutical Co Ltd
Glance View

Market Cap
445.6B JPY
Industry
Consumer products

In the bustling landscape of Japanese business, Kobayashi Pharmaceutical Co., Ltd. stands as an epitome of innovation and tradition. Founded in 1886, this company, steeped in history, has consistently demonstrated a knack for transforming simple consumer needs into thriving business opportunities. Core to its operations is the development, manufacturing, and marketing of consumer healthcare products that subtly blend pharmaceutical expertise with daily convenience. This approach has allowed Kobayashi Pharmaceutical to carve out a distinctive niche, particularly in over-the-counter (OTC) health and personal care products. The company's vast array of products is remarkably diverse, ranging from cooling gel sheets for fevers to herbal medicinal drinks, each crafted with an understanding of consumer pain points and a commitment to well-being. What sets Kobayashi apart in the competitive market is its strategic focus on niche products that serve unmet needs. This laser-sharp business model does more than just bolster its domestic market; it drives its global expansion into key markets in Asia, North America, and Europe. The company's profitability hinges not just on innovation but also on its agile response to the shifting preferences of health-conscious consumers. Driven by a mission to deliver "small but valuable products," Kobayashi’s nimble approach, coupled with an impressive R&D focus, ensures that it remains at the forefront of both consumer satisfaction and shareholder value. Much like a well-crafted Japanese garden, every part of Kobayashi's operation is meticulously designed to function harmoniously, making it a standout player in the global consumer healthcare industry.

Intrinsic Value
6 793.41 JPY
Undervaluation 12%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.9%
=
Gross Profit
91B
/
Revenue
168.8B
What is the Gross Margin of Kobayashi Pharmaceutical Co Ltd?

Based on Kobayashi Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 53.9%.